ORAL CALCITRIOL AND CALCIUM - EFFICIENT THERAPY FOR UREMIC HYPERPARATHYROIDISM

被引:78
作者
QUARLES, LD
DAVIDAI, GA
SCHWAB, SJ
BARTHOLOMAY, DW
LOBAUGH, B
机构
[1] DUKE UNIV,MED CTR,DEPT PATHOL,DURHAM,NC 27710
[2] DUKE UNIV,MED CTR,DEPT SURG,DURHAM,NC 27710
关键词
D O I
10.1038/ki.1988.258
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:840 / 844
页数:5
相关论文
共 50 条
[31]   Implications of intermittent calcitriol therapy on growth and secondary hyperparathyroidism [J].
I. B. Salusky ;
W. G. Goodman ;
B. D. Kuizon .
Pediatric Nephrology, 2000, 14 :641-645
[32]   Pamidronate facilitates calcitriol therapy in advanced secondary hyperparathyroidism [J].
Ho, LT ;
Sprague, SM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (04) :A22-A22
[33]   Implications of intermittent calcitriol therapy on growth and secondary hyperparathyroidism [J].
Salusky, IB ;
Goodman, WG ;
Kuizon, BD .
PEDIATRIC NEPHROLOGY, 2000, 14 (07) :641-+
[34]   HIGH-DOSE ORAL CALCITRIOL AND ZERO CALCIUM PERITONEAL SOLUTIONS IN CAPD PATIENTS WITH REFRACTORY SECONDARY HYPERPARATHYROIDISM [J].
MALBERTI, F ;
SCANZIANI, R ;
CORRADI, B ;
DOZIO, B ;
BONFORTE, G ;
IMBASCIATI, E ;
SURIAN, M .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (12) :1813-1815
[35]   LOW CALCIUM DIALYSATE AND HIGH-DOSE ORAL CALCITRIOL IN THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN HEMODIALYSIS-PATIENTS [J].
VANDERMERWE, WM ;
RODGER, RSC ;
GRANT, AC ;
LOGUE, FC ;
COWAN, RA ;
BEASTALL, GH ;
JUNOR, BJR ;
BRIGGS, JD .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1990, 5 (10) :874-877
[36]   CAN HYPERCALCEMIA BE AVOIDED DURING ORAL CALCITRIOL PULSE THERAPY OF SECONDARY HYPERPARATHYROIDISM IN HEMODIALYSIS-PATIENTS [J].
SZOLKIEWICZ, M ;
ZDROJEWSKI, Z ;
SULIMAGILLOW, A ;
RUTKOWSKI, B .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (09) :1781-1782
[37]   A COMPARISON OF ORAL AND INTRAVENOUS ALFACALCIDOL IN THE TREATMENT OF UREMIC HYPERPARATHYROIDISM [J].
LEE, WT ;
PADAYACHI, K ;
COLLINS, JF ;
CUNDY, T .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (06) :1344-1348
[38]   Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients [J].
Sandrine Rauscher ;
Jean-Philippe Lafrance ;
Vincent Pichette ;
Robert Z Bell ;
Katherine Desforges ;
Laurence Lepage ;
Georges Ouellet ;
Denis Ouimet ;
Martine Leblanc ;
Caroline Lamarche ;
Sarah Bezzaoucha ;
Michel Vallee .
International Urology and Nephrology, 2017, 49 :325-328
[39]   PHOSPHORUS RESTRICTION REVERSES HYPERPARATHYROIDISM IN UREMIA INDEPENDENT OF CHANGES IN CALCIUM AND CALCITRIOL [J].
LOPEZHILKER, S ;
DUSSO, AS ;
RAPP, NS ;
MARTIN, KJ ;
SLATOPOLSKY, E .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (03) :F432-F437
[40]   Low doses of calcitriol or calcium carbonate for the prevention of hyperparathyroidism in predialysis patients? [J].
Fournier, A ;
Oprisiu, R ;
Moriniere, P ;
ElEsper, N .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (07) :1493-1494